STOCK TITAN

Bausch Health Responds to Market Rumors

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) has responded to market rumors circulating in a news article by Reorg®. The company categorically denies considering any form of bankruptcy or insolvency proceedings, contrary to the unsubstantiated claims made in the initial report. Reorg® has since updated its article to clarify that Bausch Health has not engaged in discussions with creditors regarding bankruptcy. The company maintains its policy of not commenting further on speculation, emphasizing the importance of relying on official company statements for accurate information about its financial status and future plans.

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ha risposto a voci di mercato circolanti in un articolo di Reorg®. L'azienda nega categoricamente di considerare qualsiasi forma di procedimenti di bancarotta o insolvenza, contrariamente alle affermazioni infondate riportate nel documento iniziale. Reorg® ha successivamente aggiornato il suo articolo per chiarire che Bausch Health non ha intrapreso discussioni con i creditori riguardo alla bancarotta. L'azienda mantiene la propria politica di non fare ulteriori commenti sulle speculazioni, sottolineando l'importanza di fare riferimento alle dichiarazioni ufficiali dell'azienda per informazioni accurate sullo stato finanziario e sui piani futuri.

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ha respondido a rumores de mercado que circulaban en un artículo de Reorg®. La compañía niega categóricamente haber considerado cualquier forma de quiebra o procedimiento de insolvencia, en contra de las afirmaciones infundadas hechas en el informe inicial. Reorg® ha actualizado su artículo para aclarar que Bausch Health no ha participado en discusiones con acreedores sobre la quiebra. La compañía mantiene su política de no comentar más sobre especulaciones, enfatizando la importancia de confiar en las declaraciones oficiales de la empresa para obtener información precisa sobre su estado financiero y planes futuros.

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)는 Reorg®의 뉴스 기사에서 유통되고 있는 시장 소문에 응답했습니다. 이 회사는 파산 또는 지급불능 절차를 고려하고 있다는 것을 전면 부인합니다, 이는 초기 보고서에 제기된 근거 없는 주장과는 반대입니다. Reorg®는 이후 기사를 업데이트하여 Bausch Health가 파산과 관련하여 채권자와 논의하지 않았음을 명확히 하였습니다. 이 회사는 추측에 대해 추가로 언급하지 않는 정책을 유지하고 있습니다, 재무 상태 및 향후 계획에 대한 정확한 정보는 공식 회사 성명을 신뢰하는 것이 중요하다고 강조합니다.

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) a réagi aux rumeurs de marché circulant dans un article de Reorg®. La société nie catégoriquement avoir envisagé une quelconque forme de faillite ou de procédure d'insolvabilité, contrairement aux allégations infondées formulées dans le rapport initial. Reorg® a depuis mis à jour son article pour clarifier que Bausch Health n'a pas engagé de discussions avec des créanciers concernant une faillite. L'entreprise maintient sa politique de ne pas faire de commentaire supplémentaire sur les spéculations, soulignant l'importance de s'appuyer sur les déclarations officielles de l'entreprise pour obtenir des informations précises sur son statut financier et ses projets futurs.

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) hat auf Marktrumoren reagiert, die in einem Artikel von Reorg® zirkulierten. Das Unternehmen weist kategorisch zurück, in Betracht zu ziehen, irgendeine Form von Insolvenz- oder Konkursverfahren, im Gegensatz zu den unbegründeten Behauptungen im ursprünglichen Bericht. Reorg® hat daraufhin seinen Artikel aktualisiert, um klarzustellen, dass Bausch Health nicht mit Gläubigern über eine Insolvenz gesprochen hat. Das Unternehmen hält an seiner Politik fest, nicht weiter zu Spekulationen Stellung zu nehmen, und betont die Bedeutung, sich auf offizielle Unternehmensmitteilungen für genaue Informationen über seinen finanziellen Status und zukünftige Pläne zu verlassen.

Positive
  • Company firmly denies bankruptcy rumors
  • Reorg® issued a correction to its initial report
Negative
  • Circulation of unsubstantiated rumors about the company's financial status

LAVAL, QC / ACCESSWIRE / July 24, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") has become aware of a news article issued by Reorg® today, citing unnamed sources.

The article contains unsubstantiated rumors, including that the Company is considering a bankruptcy or insolvency proceeding of any kind - it is not.

We understand that Reorg® has subsequently issued an update to its original news article to clarify that the Company has not been involved in discussions with its creditors regarding bankruptcy proceedings.

The Company's policy is not to provide further comment on speculation.

About Bausch Health

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.

Forward-looking Statements

This news release may contain forward-looking statements about the future performance of Bausch Health, which may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference.Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Investor Contact:

Media Contact:

Garen Sarafian

Katie Savastano

ir@bauschhealth.com

corporate.communications@bauschhealth.com

(877) 281-6642 (toll-free)

(908) 541-3785

SOURCE: Bausch Health Companies Inc.



View the original press release on accesswire.com

FAQ

Is Bausch Health (BHC) considering bankruptcy or insolvency proceedings?

No, Bausch Health has explicitly stated that it is not considering bankruptcy or insolvency proceedings of any kind, contrary to the rumors reported by Reorg®.

How has Bausch Health (BHC) responded to the market rumors on July 24, 2024?

Bausch Health responded by denying the rumors, stating they are unsubstantiated, and clarifying that the company is not considering bankruptcy or insolvency proceedings.

Has Reorg® updated its initial news article about Bausch Health (BHC)?

Yes, Reorg® has issued an update to its original article, clarifying that Bausch Health has not been involved in discussions with creditors regarding bankruptcy proceedings.

What is Bausch Health's (BHC) policy on responding to market speculation?

Bausch Health's policy is not to provide further comment on speculation beyond their official statements.

Bausch Health Companies Inc.

NYSE:BHC

BHC Rankings

BHC Latest News

BHC Stock Data

2.25B
367.10M
1.15%
79%
5.37%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
QUEBEC